Skip to main content

MoneyWorks4Me

USFDA concludes inspection of Zydus Lifesciences’ LiqMeds, UK

14 Nov 2026 Evaluate

The United States Food and Drug Administration (USFDA) has concluded inspection of Zydus Lifesciences’ LiqMeds, UK. The inspection was conducted from November 9, 2026 and November 13, 2026. The inspection closed with 4 observations. The company will closely work with the USFDA to address the observations expeditiously. 

Zydus Lifesciences is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating, manufacturing, marketing and selling of finished dosage human formulations, active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.


Peers
Company Name CMP
Sun Pharma. Inds. 1870.30
Dr. Reddys Labs. 1383.30
Cipla 1389.95
Lupin 1951.80
Zydus Lifesciences 1202.70
View more..